| Date Filed | Type | Description |
| 06/30/2023 |
4
| Cassella James V (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $2.27, valued at
$68.1k
|
|
| 03/06/2023 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Unknown transaction of 80,595 shares
@ $0
Disposed/sold 57,766 shares
@ $0
Disposed/sold 34,700 rights
@ $0
Disposed/sold 140,000 options to buy
@ $14.46, valued at
$2M
Disposed/sold 50,000 options to buy
@ $16.85, valued at
$842.5k
Disposed/sold 70,000 options to buy
@ $10.97, valued at
$767.9k
Disposed/sold 49,500 options to buy
@ $27.59, valued at
$1.4M
Disposed/sold 75,000 options to buy
@ $13.93, valued at
$1M
Disposed/sold 42,430 options to buy
@ $10.87, valued at
$461.2k
Disposed/sold 60,400 options to buy
@ $13.07, valued at
$789.4k
|
|
| 01/31/2023 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Sold 10,106 shares
@ $8.35, valued at
$84.4k
|
|
| 01/09/2023 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,893 shares
@ $7.25, valued at
$21k
|
|
| 07/01/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2022 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Sold 2,894 shares
@ $3.19, valued at
$9.2k
|
|
| 08/17/2021 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Sold 8,086 shares
@ $3.28, valued at
$26.5k
|
|
| 06/17/2021 |
4
| Cassella James V (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.25, valued at
$45k
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Sold 4,354 shares
@ $10.37, valued at
$45.2k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Cassella James V (Director) has filed a Form 4 on Trevi Therapeutics, Inc.|
Txns:
| Granted 23,684 options to buy
@ $5.5, valued at
$130.3k
|
|
| 02/18/2020 |
3
| Cassella James V (Director) has filed a Form 3 on Trevi Therapeutics, Inc. |
| 08/19/2019 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Granted 31,100 shares
@ $0 |
|
| 04/02/2019 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 8,835 shares
@ $12.07, valued at
$106.6k
|
|
| 01/08/2019 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Granted 75,000 options to buy
@ $13.93, valued at
$1M
|
|
| 04/19/2018 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Sold 10,582 shares
@ $20.1767, valued at
$213.5k
|
|
| 04/13/2018 |
4/A
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 4,418 shares
@ $22.9, valued at
$101.2k
|
|
| 04/03/2018 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 4,418 shares
@ $22.9, valued at
$101.2k
|
|
| 01/08/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2017 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Granted 60,000 shares
@ $0 |
|
| 01/06/2017 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC. |
| 01/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/04/2015 |
4
| Cassella James V (Former EVP, R&D and CSO) has filed a Form 4 on Alexza Pharmaceuticals Inc. |
| 03/06/2015 |
4
| Cassella James V (Chief Development Officer) has filed a Form 4 on CONCERT PHARMACEUTICALS, INC.|
Txns:
| Granted 140,000 options to buy
@ $14.46, valued at
$2M
|
|
| 07/08/2014 |
4
| Cassella James V (EVP, R&D and CSO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 25,000 options to buy
@ $4.45, valued at
$111.3k
|
|
| 06/30/2014 |
4
| Cassella James V (EVP, R&D and CSO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 125,000 options to buy
@ $4.57, valued at
$571.3k
|
|
| 04/02/2013 |
4/A
| Cassella James V (EVP, R&D and CSO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 43,750 shares
@ $4.42, valued at
$193.4k
Granted 87,500 options to buy
@ $4.42, valued at
$386.8k
|
|
| 04/02/2013 |
4
| Cassella James V (EVP, R&D and CSO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 43,750 shares
@ $4.42, valued at
$193.4k
Granted 43,750 options to buy
@ $4.42, valued at
$193.4k
|
|
| 02/08/2013 |
4
| Cassella James V (EVP, R&D and CSO) has filed a Form 4 on Alexza Pharmaceuticals Inc.|
Txns:
| Granted 17,795 shares
@ $0 |
|
|